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ABSTRACT 
Objective: To investigate the phytoconstituents and in vitro cytotoxicity of methanol (MeOH) and aqueous (AQE) extracts of Benkara malabarica 
(Lam.) Triveng (BM) plant leaves. 
Methods: Gas chromatography-mass spectrometry (GC MS) was carried out to disclose the principal phytoconstituents present in MeOH and AQE 
extracts of BM. In vitro cytotoxicity of BM extracts were determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
Acridine orange (AO)/ethidium bromide (EB) and 4', 6-diamidino-2-phenylindole (DAPI) staining were performed to visualize morphological 
changes upon treatment of BM extracts. Fluorescence-activated cell sorting (FACS) was carried out to determine the apoptosis and cell cycle 
arrestability of BM extracts. 
Results: GC MS analysis reported the presence of nine phytoconstituents in MeOH and AQE extracts of BM. The IC50 of BM MeOH, AQE extracts 
treated K562 cells were 49.78±1.697, 15.47±1.19 µg/ml for 48 h and found to be statistically significant (p<0.001). AO/EB and DAPI staining results 
anticipated the induction of apoptosis and DNA fragmentation upon treatment of BM extracts. FACS analysis revealed the SubG0
Conclusion: The results of the present study uncovered that the BM AQE extract was more potent in inhibiting K562 cell proliferation through cell 
cycle arrest and apoptosis compared to the MeOH extract of BM.  
 cell populations 
increased in K562 cells treated by BM MeOH (18.15) and AQE (51.26) extracts. 
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Medicinal plants are extensively used all over the world as folk medicine 
because they are cost-effective and inexpensive alternative sources of 
drugs due to their less side effects [1-3]. Plants are a rich source of 
secondary metabolites such as flavonoids, carotenoids, phenols, 
alkaloids, terpenoids, saponins and steroids. These secondary 
metabolites of plant origin have exhibited antimicrobial, antioxidant and 
anticancer activities [4, 5]. According to World Health Organization 
(WHO) reports, approximately 65-80 % of the world population use 
traditional medicine to treat various diseases. Interestingly, 50 % of all 
modern clinical drugs are of natural product origin [6-8].  
Chronic myeloid leukemia (CML) is a hematoproliferative neoplasm that 
is marked by uncontrolled myeloid cell divisions in bone marrow. The 
hallmark of CML is the presence of shortened Philadelphia chromosome 
(Ph) which arises due to a reciprocal translocation between 
chromosome 9 and chromosome 22 [(9;22) (q34;q11)], leading to the 
creation of bcr-abl oncogene. This bcr-abl oncogene encodes a 
constitutively activated tyrosine kinase, BCR-ABL. The catalytically 
activated kinase, in turn, activates multiple cell proliferatory signalling 
pathways such as RAS, a small GTPase, mitogen-activated protein kinase 
(MAPK), signal transducers and activator of transcription (STAT) and 
phosphoinositide-3-kinase (PI3K) pathways [9-12]. Tyrosine kinase 
inhibitors (TKIs) like imatinib [13], nilotinib, dasatinib, bosutinib [14] 
and ponatinib [15] were approved by the US Food and Drug 
Administration (FDA). TKIs have changed the clinical course of CML; 
however, mutations in bcr-abl and multi-drug resistance (MDR) due to 
efflux of the drug because of overexpression of p-glycoprotein (p-gp) 
make TKIs less effective. Hence, there is a need for an alternative 
strategy to develop new BCR-ABL inhibitors. Clearly, natural products 
obtained from plants offer an alternate, effective and inexpensive source 
for CML therapy [16]. 
K562 is a BCR-ABL positive CML cell line that was established from a 
53-year-old woman with CML. After 176 passages in 3.5 y, the K562 
cell line still has active CML cells in blast crisis stage with Ph [17, 18]. 
In the present study, the in vitro cytotoxicity of Benkara malabarica 
(Lam.) Tirveng (BM) extracts were evaluated against K562 cells. 
Previous reports suggest that BM leaf and bark extracts reported 
anti-bacterial and anti-fungal activities [19]. BM methanol (MeOH) 
root extract had reported anti-convulsant activity against isoniazide 
induced convulsion in in vivo models [20]. 
MATERIALS AND METHODS 
Chemicals and reagents 
All the chemicals and reagents used in this work were purchased 
from Hi-media Pvt. Ltd, Bombay, India.  
Cell culture 
K562 cell line was obtained from the National Centre for Cell 
Sciences (NCCS), Pune and were maintained in RPMI medium (pH 
7.4) supplemented with 10 % fetal bovine serum (FBS) and 
antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin) at 37 
°C in a humidified 5 % CO2
Collection and identification of plant material 
 atmosphere. 
BM plant leaves were collected inside the Pondicherry University 
campus. The plant sample was identified and authenticated by Dr. N. 
Ayyappan, French Institute of Pondicherry (IFP), Puducherry. BM 
herbarium specimen was deposited at IFP with accession number 
HIFP27056. 
Preparation of BM extracts 
100 g of BM leaf powder was extracted with both 500 ml of MeOH 
and water (AQE) using soxhlet apparatus. Extract solution was then 
filtered through Whatman No.1 filter paper and concentrated using 
rota-vapour. The concentrated BM extracts were stored at 4 °C until 
further use. 
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Estimation of total phenolic content (TPC) 
MeOH and AQE extracts of BM in the concentration (conc.) range of 
40-200 μg were taken and adjusted to 20 μl with distilled water. 
Then, 50 μl of Folin–Ciocalteu (FC) reagent (1/10 dilution) was 
added and incubated for 5 min at room temperature (RT). This was 
followed by the addition of 50 μl of sodium carbonate solution (7.5 
%). The absorbance was measured at 760 nm. Gallic acid was used 
as a standard for the calibration curve. The TPC was expressed as 
gallic acid equivalents (GAE) [21]. 
Estimation of total flavonoid content (TFC) 
TFC of the BM plant extracts was determined by the aluminium 
chloride method as described [22]. MeOH and AQE extracts of BM of 
varying conc. (40-200 μg) were taken and was made up to 10 μl with 
the solvent (MeOH and Distilled water). Then, 30 μl of sodium nitrite 
(0.03 %) was added and incubated for 5 min at RT followed by the 
addition of 30 μl of aluminium chloride (10 %) solution. Incubation 
was carried for 5 min at RT and 200 μl of 1 mmol sodium hydroxide 
was added. The total volume was then made up to 1000 μl with 
distilled water and the absorbance was measured at 510 nm. 
Various conc. of standard quercetin was used to make a standard 
calibration curve. TFC was expressed as quercetin equivalents (QE). 
Gas chromatography-mass spectrometry (GC MS) analysis 
GC MS analysis of MeOH and AQE extracts of BM was carried out using 
Clarus 500 Perkin–Elmer (auto system XL) of as previously described 
[23]. Using MS data library on a National Institute of Standards and 
Technology (NIST) Ver.2.1 and comparing the spectrum obtained 
through GC MS revealed compounds present in the BM extracts. 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay 
K562 cells were plated in a 96-well tissue culture plates at a density of 
approximately 5,000 cells per well. The cells were then incubated with 
100 μl of MeOH and AQE extracts of BM in the conc. range (2, 4, 8, 16, 32 
and 64 μg) for 48 h. Untreated cells were used as a control and blank 
wells containing 100 μl of medium only. After 48 h of incubation, 20 μl of 
the MTT reagent (5 mg/ml) was added to each well and the plate was 
incubated for 4 h at 37 °C. Then the plate was centrifuged at 1500 rpm 
for 5 min. The supernatant was discarded and to the pellet 150 μl of 
dimethyl sulphoxide (DMSO) was added to each well and absorbance 
was read at 595 nm using Aspinco biotech Elisa plate reader [24]. 
Acridine orange (AO)/ethidium bromide (EB) staining 
Approximately 1x105K562 cells were seeded in 6-well tissue culture 
plate. Cells were then treated with IC50 
4',6-diamidino-2-phenylindole (DAPI) staining 
conc. of BM MeOH and AQE 
extracts for 48 h. After 48 h of treatment, cells were harvested and 
washed once with phosphate buffer saline (PBS) (pH 7.4) and 
stained with AO/EB (1 µg/ml) for 10 min. The stained cells were 
then examined under a Nikon Eclipse Ti fluorescence microscope 
(Nikon Instruments Inc., NY, USA) using a UV filter (450-490 nm). 
Untreated cells were used as control [25]. 
Approximately 1x105 K562 cells were seeded into 6-well tissue 
culture plates. Then, the cells were treated with IC50
Cell cycle analysis 
 conc. of MeOH 
and AQE extracts of BM for 48 h following which cells were 
harvested and washed once with PBS (pH 7.4) and fixed with 4 % 
paraformaldehyde for 30 min. The fixed cells were stained with 
DAPI (1 µg/ml) for 10 min examined under a Nikon Eclipse Ti 
fluorescence microscope (Nikon Instruments Inc., NY, USA) using a 
UV filter (450-490 nm). Untreated cells were used as control [26].  
Briefly, 1x106K562 cells were seeded in 6 well plates and treated with 
the IC50
Statistical analysis 
All experiments were carried out in triplicates. The values are 
represented as a mean±standard deviation (SD). IC
 conc. of BM extracts for 48 h at 37 °C. Subsequently, cells were 
harvested, washed with ice-cold PBS and fixed in 70 % ethanol at 4 °C 
for overnight. The fixed cells were then incubated with 0.5 ml of 
propidium iodide (PI) (50 µg/ml) solution containing triton X-100 (0.1 
%), sodium citrate (0.1 %) and RNase-A (25 µg/ml) for 10 min under 
the dark. The percentage of cells in various phases of the cell cycle was 
assessed in a BD FACS CALIBUR instrument [27, 28]. 
50
RESULTS AND DISCUSSION 
 values of BM 
extracts in MTT assay were determined using non-linear regression 
employing GraphPad prism software. MTT results were analysed 
using a one-way analysis of variance (ANOVA) followed by Tukey's 
multiple comparisons tests where p value<0.001 took as significant 
using SPSS software. 
TPC and TFC 
Phenols and flavonoids are among the most widely occurring 
secondary metabolites present in plants. Phenols are aromatic 
compounds which contain one or several hydroxyl groups directly 
attached to the benzene ring. Phenolic compounds exhibit 
antioxidant, anti-mutagenic and anti-cancer activities [29, 30]. TPC 
in BM extracts was deduced from the standard curve of gallic acid 
(fig. 1A) (Y = 0.017x-0.004 and R2 = 0.990). The TPC content of 
MeOH and AQE extracts of BM had contained 238.5 and 312 µg/mg 
of GAE (fig. 1B). Flavonoids belong to polyphenolic compounds 
which are prevalent in plants. They contain two phenyl rings A, B and a 
heterocyclic ring C (commonly referred to as a C6-C3-C6 skeleton). 
Flavonoids exhibit antioxidant, anti-inflammatory, antibacterial, 
antiviral and anticancer activities [31, 32]. The TFC in BM extracts was 
derived from the standard curve of quercetin (Y = 0.002x-0.000 and R2
 
 
= 0.989) (fig. 2A). TFC content of MeOH and AQE extracts of BM was 
found to be 798.5 and 333 µg/mg of QE (fig. 2B). 
 
Fig. 1: TPC of BM extracts, A): Standard curve for gallic acid. B): TPC of MeOH and AQE extracts of BM. TPC was more in AQE compared to 
MeOH extract of BM. Values were represented as mean±SD (n=3) 
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Fig. 2: TFC of BM extracts, A): Standard curve for quercetin. B): TFC of MeOH and AQE extracts of BM. TFC was more in MeOH compared to 
AQE extract of BM, values were represented as mean±SD (n=3) 
 
 
Fig. 3: GC MS chromatograph of BM extracts, A): GC MS chromatograph of BM MeOH extract showed various compounds at major peaks 
like 18.83–9-Octadecenoic acid [Z]-, methyl ester, 12.53–phenol,2,4-bis[1,1-dimethylethyl]-, 19.43–2-methyl-Z,Z-3,13-Octadecadienol and 
21.6–benzene1,1-1l-[1-(2,2-dimethyl-3-butenyl)-1,3-propanediyl]bis-were present. B): GC MS chromatograph of BM AQE extract major 
peaks at 18.83, 17.15, 20.32 and 22.7 corresponds to 10-octadecenoic acid methyl ester, hexadecanoic acid methyl ester, Isopropyl 
stearate and 2-Cyclohexen-3,6-diol-1-one,2-tetradecanoyl 
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GC MS analysis 
GC MS analysis was based on the computer evaluation of mass 
spectra of samples through NIST based software, direct comparison 
of peaks and retention time with those of standard compounds and 
computer matching with the NIST library. Both MeOH (fig. 3A) and 




Fig. 4: List of phyto-constituents identified in GC MS chromatograph of MeOH extract of BM, A): Phenol,2,4-bis[1,1-dimethylethyl], B): 2-
hexadecanol, C): 4H-1-Benzopyran-4-one,5-hydroxy-7-methoxy-2-phenyl, D): 11-Tricosene, E): 9-Octadecenoic acid [Z]-, methyl ester, F): 
2-methyl-Z,Z-3,13-Octadecadienol, G): Ethanol,2-(9-octadecenyloxy) [Z]-, H): Benzene1,1-1l
 
-[1-(2,2-dimethyl-3-butenyl)-1,3-
propanediyl]bis-and I): Quinoline-4-carboxylic acid, 2-(4-isopropylphenyl) 
Various phytoconstituents present in MeOH and AQE extracts of BM were illustrated in fig. 4 and fig. 5. 
 
 
Fig. 5: List of phyto-constituents identified in GC MS chromatograph of AQE extract of BM, A): Hexadecanoic acid methyl ester, B): 10-
Octadecenoic acid methyl ester, C): 4H-1-Benzopyran-4-one,2-[3,4-dimethoxyphenyl]-7-hydroxy, D): 10,13-Eicosadienoic acid, methyl 
ester E): Isopropyl stearate, F): Tricosan-2-ol, G): 2-Cyclohexen-3,6-diol-1-one,2-tetradecanoyl, H): Pyrano[4,3-b]benzopyran-1,9-
dione,5a-methoxy-9a-methyl-3-[1-propenyl]perhydro-and I): Cyclohexan-1-one-3a,5a diacetic acid,2a(-5 hydroxy-2,4-dimethoxyphenyl)-
diethyl ester 
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MTT assay was performed to determine the cytotoxicity of BM 
MeOH and AQE extracts (fig. 6) against K562 cells for 48 h. Both 
BM extracts decreased K562 cell proliferation in a dose-
dependent manner. The IC 50
 
 of MeOH and AQE extracts of BM 
was found to be 49.78±1.697 and 15.47±1.19 µg/ml respectively. 
The results of our assay revealed that AQE extract was more 
potent than the MeOH extract in reducing the K562 cell 
proliferation. 
 
Fig. 6: MTT assay of BM extracts treated K562 cells for 48 h, values were represented as mean±SD (n=3). Statistical analysis of the 
experimental results was performed using ANOVA followed by Tukey's multiple comparisons to control in which ** represent p<0.001 
took as significant 
 
AO/EB staining 
Nuclear changes and apoptotic body formation are a 
characteristic feature of apoptosis, which can be visualized by 
AO/EB staining [33]. K562 untreated cells appear uniformly 
green, whereas dead cells appear orange in colour. AQE extract 
of BM (fig. 7C) was more potent in inducing cell death in K562 
cells compared to the MeOH extract-treated cells (fig. 7B). 
DAPI staining 
Blue-fluorescent DAPI stain preferentially binds to the AT-rich regions 
of the minor groove of double-stranded (ds) DNA [34]. Binding of DAPI 
to dsDNA (resulting from DNA defragmentation) increase 
approximately 20-fold fluorescence enhancement, which was evident 
in the AQE treated K562 cells (fig. 7F) compared to MeOH extract (fig. 
7E). Morphological changes observed in the treated cells displayed 
broken nuclei as discrete fragments. 
 
 
Fig. 7: AO/EB and DAPI staining of K562 cells treated with IC50 conc. of BM MeOH and AQE extracts for 48 h and images were captured 
under 20 X magnification. A): In AO/EB staining untreated K562 cells showed green fluorescence. B): BM MeOH and C): AQE extracts 
treated K562 cells undergoing apoptosis (represented by an arrow mark) appeared as an orange colour. D): In DAPI staining untreated 
K562 cells visualized as normal blue colour whereas E): BM MeOH and F): AQE extracts treated K562 cells undergoing DNA fragmentation 
(represented by an arrow mark) showed more intensity in blue colour 
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Cell cycle analysis 
PI is used as a DNA stain in flow cytometry to evaluate cell 
viability or DNA content in cell cycle analysis. It is useful for 
differentiating necrotic (or) apoptotic and normal cells [35]. To 
determine whether the MeOH and AQE extracts of BM induced cell 
cycle arrest in the K562 cells, the DNA content was measured by 
FACS using PI staining. There was a significant increase in SubG0 
population to 51.26 (fig. 8C) and 18.15 (fig. 8B) in K562 cells treated 
with AQE and MeOH extracts of BM. Concomitantly, a decrease in 
G0/G1 
 
(from 63.04 to 38.93 and 53.04) and S phases (from 24.73 to 
6.20 and 13.67) for AQE and MeOH extracts of BM was observed. 
The results confirmed that K562 cells upon treatment of BM extracts 
induce apoptosis. 
 
Fig. 8: Cell cycle analysis of BM extracts treated K562 cells. A): K562 untreated cells. B): induction of apoptosis (sub-G0
 
 phase) by BM 
MeOH, C): AQE extracts for 48 h revealed by PI staining 
CONCLUSION 
Plants are being investigated extensively for their pharmacological 
purpose as potent anti-cancer drugs. In the present study, BM MeOH 
and AQE crude extracts were being used to examine their 
cytotoxicity towards CML cell line. Secondary metabolites like 
phenols and flavonoids were estimated. TPC was more in AQE 
extract than the MeOH extract of BM. TFC was high in MeOH extract 
of BM compared to AQE extract of BM. GC MS analysis revealed nine 
important phytoconstituents in MeOH and AQE extracts of BM. In 
vitro cytotoxicity of these extracts was tested against K562 cells. 
AO/EB staining, DAPI staining and cell cycle analysis revealed that 
AQE extract is more potent than the MeOH extract of BM in inducing 
apoptosis in K562 cells. Further studies are required to provide 
more comprehensive data on the anti-CML activity of the AQE and 
MeOH extracts of BM.  
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